Concepedia

Author

Aliza Ackerstein

Hadassah Academic College

Also Known As

A ACKERSTEIN, A Ackerstein, A. Ackerstein, ALIZA ACKERSTEIN, Aliza Ackerstein

109

Publications

6.8K

Citations

26

H-Index

62

Concepts

All Affiliations

Hadassah Academic CollegeHadassah Medical CenterSheba Medical CenterHebrew University of JerusalemTel Aviv University
AA

About

Aliza Ackerstein is an author at Hadassah Academic College specializing in medicine, cell transplantation, and transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

20

27

1.3K

2

Health Sciences

8

8

267

3

Allergy

2

2

64

4

Engineering

1

1

570

5

Biomedical Engineering

1

1

29

Aliza Ackerstein

×

53

Publications

6.6K

Citations

26

H-Index

YearCitations

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

Shimon Slavin, Arnon Nagler, E Naparstek,

Blood

1998

1.9K

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

Shimon Slavin, Arnon Nagler, E Naparstek,

Blood

1998

1.8K

Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial

Jordi Rodón, Jean‐Charles Soria, Raanan Berger,

Nature Medicine

2019

570

Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation

S Slavin, E Naparstek, A Nagler,

Blood

1996

418

Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase

Reuven Or, Michael Y. Shapira, Igor Resnick,

Blood

2002

213

Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.

S Slavin, Elizabeth Naparstek, Arnon Nagler,

PubMed

1995

213

The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R

David J. Gross, Gabriel Munter, Menachem Bitan,

Endocrine Related Cancer

2006

135

The graft-versus-leukemia (GVL) phenomenon: is GVL separable from GVHD?

Shimon Slavin, Aliza Ackerstein, Elizabeth Naparstek,

PubMed

1990

110

Immunotherapy With Recombinant Human Interleukin-2 and Recombinant Interferon-α in Lymphoma Patients Postautologous Marrow or Stem Cell Transplantation

Arnon Nagler, Aliza Ackerstein, Reuven Or,

Blood

1997

85

Use of recombinant human interleukin-2 in conjunction with syngeneic bone marrow transplantation in mice as a model for control of minimal residual disease in malignant hematologic disorders

Aliza Ackerstein, Eli Kedar, S Slavin

Blood

1991

60

Page 1